Clinical Utility- Determining eligibility of and monitoring treatment with anti-EGFR therapy (cetuximab and panitumumab)
- As an aid in diagnosis and management of melanoma
- As an aid in diagnosis and management of colorectal cancer
- As an aid in diagnosis and management of lung cancer
- As an aid in diagnosis and management of thyroid cancer
- Therapy monitoring and disease management